524604 Stock Overview
Adline Chem Lab Limited markets pharmaceutical products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Adline Chem Lab Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹24.99 |
| 52 Week High | ₹28.97 |
| 52 Week Low | ₹11.92 |
| Beta | 0 |
| 11 Month Change | -3.92% |
| 3 Month Change | 40.31% |
| 1 Year Change | 11.02% |
| 33 Year Change | 371.51% |
| 5 Year Change | 338.42% |
| Change since IPO | 99.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524604 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 0% | -2.3% | -3.4% |
| 1Y | 11.0% | 36.8% | 27.0% |
Return vs Industry: 524604 underperformed the Indian Healthcare industry which returned 36.8% over the past year.
Return vs Market: 524604 underperformed the Indian Market which returned 27% over the past year.
Price Volatility
| 524604 volatility | |
|---|---|
| 524604 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine 524604's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | n/a | www.kamronlabs.com |
Adline Chem Lab Limited markets pharmaceutical products in India and internationally. It also offers anti-infectives, gastroentology, haemostatic, padeatric, and bone health pharmaceutical related products. In addition, it provides hepatocare, pain and inflammation, pregnancy and reproductive care, respiratory care, and multi-vitamins in tablet, capsule, liquid orals, and injection forms.
Adline Chem Lab Limited Fundamentals Summary
| 524604 fundamental statistics | |
|---|---|
| Market cap | ₹146.19m |
| Earnings (TTM) | ₹0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 524604 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524604 income statement (TTM) | |
|---|---|
| Revenue | ₹0 |
| Cost of Revenue | ₹0 |
| Gross Profit | ₹0 |
| Other Expenses | ₹0 |
| Earnings | ₹0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 524604 perform over the long term?
See historical performance and comparison